Nalaganje...
Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer
Prostate cancer (PCa) is the most common malignancy, and the third leading cancer-related cause of death among men of the Western world. Upon PCa progression into metastatic disease, androgen deprivation therapy is applied as the first-line treatment, and has been shown to be effective in most patie...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2013
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3762760/ https://ncbi.nlm.nih.gov/pubmed/24009414 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S45703 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|